These results suggest that a specific blockade of CHK2 activity by NSC109555 significantly enhances GEM-induced apoptotic cell death via activation of caspase-3/7 and PARP cleavage in pancreatic cancer cells. The gene discussed is CASP3; the disease is familial pancreatic carcinoma.